Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
PercuSense, Inc. is an innovative medical device company at the forefront of developing next-generation continuous monitoring technology. Their core focus is a minimally invasive sensor designed to simultaneously track multiple key analytes (biomarkers) in the body, beyond just glucose. This technology aims to provide users and healthcare providers with comprehensive, real-time physiological data, empowering proactive health management, improving outcomes for chronic conditions such as diabetes and kidney disease, and offering valuable insights for general wellness and fitness.
The headquarters serves as the central hub for all company operations, including cutting-edge research and development, product engineering, clinical and regulatory affairs, and corporate administration for its multi-analyte sensor technology.
Situated within a modern technology park, the facility provides an environment conducive to innovation, with access to shared amenities and a network of other tech-focused organizations.
The work culture at PercuSense is likely dynamic and mission-driven, characterized by a strong emphasis on scientific innovation, collaborative problem-solving, and a commitment to advancing medical technology for patient benefit. Employees are expected to be passionate about making a tangible impact in healthcare.
This Trumbull location is critical as it houses the core R&D and engineering teams spearheading the development of PercuSense's proprietary sensor technology. Its proximity to Connecticut's life sciences corridor also offers advantages in talent acquisition and potential collaborations.
Currently, PercuSense's operations are primarily centered in the United States, with a focus on research, development, and securing regulatory approvals. While their innovative multi-analyte sensor technology has global health applications, their direct global operational footprint is still developing. Future global expansion will likely involve strategic partnerships for clinical trials, manufacturing, distribution, and market entry in key international regions once product commercialization stages are reached.
100 Technology Drive, Suite 325
Trumbull
CT
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, PercuSense' leadership includes:
PercuSense has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no significant new executive hires or departures announced at PercuSense in the last 12 months. The company's leadership team appears to be stable as it continues to advance its sensor technology development.
Discover the tools PercuSense uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats for companies like PercuSense often use a combination of the employee's first name, last name, or initials. While the exact format isn't publicly confirmed by the company, a highly probable pattern is [first_initial][last]@percusense.com. For any critical communication, direct verification through official channels is recommended.
[first_initial][last]@percusense.com
Format
bkannard@percusense.com
Example
75%
Success rate
PR Newswire • August 2, 2022
PercuSense, Inc., a medical device company developing a continuous multi-analyte sensor for proactive health management, announced the completion of an oversubscribed $2.15 million SAFE (Simple Agreement for Future Equity) financing round. The funds will be used to accelerate the development of its novel sensor technology....more
PercuSense News / NIH Reporter • June 9, 2021
PercuSense, Inc. announced it has been awarded a $2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The grant will support the continued development and validation of PercuSense's novel continuous multi-analyte sensor....more
PR Newswire • February 23, 2021
PercuSense, Inc. today announced the closing of a $3.65 million Series A financing. The round was led by Connecticut Innovations and Quark Venture LP, with participation from SOSV and Main Sequence Ventures. The funding will advance the development of its continuous multi-analyte sensor platform designed for improved management of chronic diseases and general health....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including PercuSense, are just a search away.